A detailed history of Nicholas Investment Partners, LP transactions in Glaukos Corp stock. As of the latest transaction made, Nicholas Investment Partners, LP holds 20,724 shares of GKOS stock, worth $2.87 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares
20,724
Holding current value
$2.87 Million
% of portfolio
0.3%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$113.62 - $135.39 $2.35 Million - $2.81 Million
20,724 New
20,724 $2.7 Million
Q1 2024

May 13, 2024

BUY
$76.4 - $96.33 $850,790 - $1.07 Million
11,136 Added 39.38%
39,416 $3.72 Million
Q4 2023

Feb 07, 2024

BUY
$59.53 - $85.11 $1.68 Million - $2.41 Million
28,280 New
28,280 $2.25 Million

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $6.59B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Nicholas Investment Partners, LP Portfolio

Follow Nicholas Investment Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicholas Investment Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Nicholas Investment Partners, LP with notifications on news.